Rawcliffe Adrian 4
4 · Wave Life Sciences Ltd. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
Rawcliffe Adrian
Director
Transactions
- Sale
Ordinary Shares
2025-11-13$6.79/sh−16,115$109,421→ 12,700 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.64 to $7.00 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.